BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26679179)

  • 1. Iodine concentration as a perfusion surrogate marker in oncology: Further elucidation of the underlying mechanisms using Volume Perfusion CT with 80 kVp.
    Thaiss WM; Haberland U; Kaufmann S; Spira D; Thomas C; Nikolaou K; Horger M; Sauter AW
    Eur Radiol; 2016 Sep; 26(9):2929-36. PubMed ID: 26679179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose Optimization of Perfusion-derived Response Assessment in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: Comparison of Volume Perfusion CT and Iodine Concentration.
    Thaiss WM; Haberland U; Kaufmann S; Hepp T; Schulze M; Blum AC; Ketelsen D; Nikolaou K; Horger M; Sauter AW
    Acad Radiol; 2019 Sep; 26(9):1154-1163. PubMed ID: 30482626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of hepatocellular carcinoma (HCC) lesions using a novel CT-based volume perfusion (VPCT) technique.
    Kaufmann S; Horger T; Oelker A; Kloth C; Nikolaou K; Schulze M; Horger M
    Eur J Radiol; 2015 Jun; 84(6):1029-35. PubMed ID: 25816994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can dual-energy CT replace perfusion CT for the functional evaluation of advanced hepatocellular carcinoma?
    Mulé S; Pigneur F; Quelever R; Tenenhaus A; Baranes L; Richard P; Tacher V; Herin E; Pasquier H; Ronot M; Rahmouni A; Vilgrain V; Luciani A
    Eur Radiol; 2018 May; 28(5):1977-1985. PubMed ID: 29168007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report.
    Kaufmann S; Schulze M; Spira D; Horger M
    Acta Radiol; 2016 Jan; 57(1):8-12. PubMed ID: 25585848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volume perfusion computed tomography (VPCT)-based evaluation of response to TACE using two different sized drug eluting beads in patients with nonresectable hepatocellular carcinoma: Impact on tumor and liver parenchymal vascularisation.
    Kaufmann S; Horger T; Oelker A; Beck S; Schulze M; Nikolaou K; Ketelsen D; Horger M
    Eur J Radiol; 2015 Dec; 84(12):2548-54. PubMed ID: 26428842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between Dual-Energy and Perfusion CT in Patients with Hepatocellular Carcinoma.
    Gordic S; Puippe GD; Krauss B; Klotz E; Desbiolles L; Lesurtel M; Müllhaupt B; Pfammatter T; Alkadhi H
    Radiology; 2016 Jul; 280(1):78-87. PubMed ID: 26824712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Image quality of mean temporal arterial and mean temporal portal venous phase images calculated from low dose dynamic volume perfusion CT datasets in patients with hepatocellular carcinoma and pancreatic cancer.
    Wang X; Henzler T; Gawlitza J; Diehl S; Wilhelm T; Schoenberg SO; Jin ZY; Xue HD; Smakic A
    Eur J Radiol; 2016 Nov; 85(11):2104-2110. PubMed ID: 27776665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.
    Kloth C; Thaiss WM; Kärgel R; Grimmer R; Fritz J; Ioanoviciu SD; Ketelsen D; Nikolaou K; Horger M
    Acad Radiol; 2017 Nov; 24(11):1352-1363. PubMed ID: 28652049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of dual-energy and perfusion CT parameters for diagnosing solitary pulmonary nodules.
    Zhu B; Zheng S; Jiang T; Hu B
    Thorac Cancer; 2021 Oct; 12(20):2691-2697. PubMed ID: 34409741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of variability in breath-hold perfusion CT of hepatocellular carcinoma: a step toward clinical use.
    Petralia G; Summers P; Viotti S; Montefrancesco R; Raimondi S; Bellomi M
    Radiology; 2012 Nov; 265(2):448-56. PubMed ID: 22996748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGFR-2 expression in HCC, dysplastic and regenerative liver nodules, and correlation with pre-biopsy Dynamic Contrast Enhanced CT.
    Thaiss WM; Kaufmann S; Kloth C; Nikolaou K; Bösmüller H; Horger M
    Eur J Radiol; 2016 Nov; 85(11):2036-2041. PubMed ID: 27776657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between acoustic radiation force impulse quantification data and perfusion-CT parameters in hepatocellular carcinoma.
    Esser M; Schneeweiß S; Kolb M; Kurucay M; Ruff C; Nikolaou K; Horger M
    Eur J Radiol; 2017 Apr; 89():215-220. PubMed ID: 28267542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences Between CT-Perfusion and Biphasic Contrast-enhanced CT for Detection and Characterization of Hepatocellular Carcinoma: Potential Explanations for Discrepant Cases.
    Perl RM; Portugall J; Hinterleitner C; Hinterleitner M; Kloth C; Walter SS; Bitzer M; Horger MS
    Anticancer Res; 2021 Mar; 41(3):1451-1458. PubMed ID: 33788737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducibility of VPCT parameters in the normal pancreas: comparison of two different kinetic calculation models.
    Kaufmann S; Schulze M; Horger T; Oelker A; Nikolaou K; Horger M
    Acad Radiol; 2015 Sep; 22(9):1099-105. PubMed ID: 26112056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Hepatic Perfusion Using GRASP MRI: Bringing Liver MRI on a New Level.
    Weiss J; Ruff C; Grosse U; Grözinger G; Horger M; Nikolaou K; Gatidis S
    Invest Radiol; 2019 Dec; 54(12):737-743. PubMed ID: 31206392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT: which parameters work best?
    Kurucay M; Kloth C; Kaufmann S; Nikolaou K; Bösmüller H; Horger M; Thaiss WM
    Cancer Imaging; 2017 Jun; 17(1):18. PubMed ID: 28659180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the nature of residual masses at end of treatment in lymphoma patients using volume perfusion computed tomography.
    Syha R; Grünwald L; Horger T; Spira D; Ketelsen D; Vogel W; Claussen CD; Horger M
    Eur Radiol; 2014 Mar; 24(3):770-9. PubMed ID: 24306426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging.
    Ippolito D; Capraro C; Casiraghi A; Cestari C; Sironi S
    Eur Radiol; 2012 Apr; 22(4):803-11. PubMed ID: 22086560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transarterial Chemoembolization of Hepatocellular Carcinoma Using Radiopaque Drug-Eluting Embolics: How to Pursue Periprocedural Cross-Sectional Imaging?
    Ruff C; Grözinger G; Syha R; Elser S; Partovi S; Bitzer M; Horger M; Nikolaou K; Grosse U
    J Vasc Interv Radiol; 2019 Mar; 30(3):380-389.e4. PubMed ID: 30819480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.